Announcement

Max Jones

Max Jones is the producer for The Chris Hedges Report. After graduating from the University of Southern California in 2023, his work has been published in Unlimited Hangout, ScheerPost and republished at Popular Resistance.

Number of Articles 7 Articles
Socials
Max Jones's Work 7 Articles
Feb 18, 2026

Robert Kadlec: The Man Behind Trump’s Biowarfare Policy

Robert Kadlec: The Man Behind Trump’s Biowarfare Policy

Robert Kadlec, a veteran of biowarfare with longstanding connections to the National Security State and corrupt government contractors as well as controversial Covid-19 policies, has now become the head of counterproliferation policy at the Department of War.

Max Jones
Nov 06, 2025

Cold Harbor: Eugenics, Epstein and Big Tech

Cold Harbor: Eugenics, Epstein and Big Tech

Epstein’s emails reveal his fascination with neo-eugenics: DNA, life extension, a “baby ranch.” The same obsessions drive Thiel, Musk, and other tech oligarchs, whose data-hungry transhumanism treats humans as parts to be optimized.

Max Jones
Aug 18, 2025

Meet Trump's CDC Director: Susan Monarez

Meet Trump's CDC Director: Susan Monarez

A closer look at the CDC director’s history and connections reveal that her government career is closely linked to the intersections of re-branded eugenics, the militarization of healthcare and the expansion of the bio-surveillance state.

Max Jones
Jan 13, 2025

The CDC, Palantir and the AI-Healthcare Revolution

The CDC, Palantir and the AI-Healthcare Revolution

The CDC’s Center for Forecasting and Outbreak Analytics (CFA) has partnered with the CIA-linked Palantir to cement the public-private model of invasive surveillance in “public health,” all while pushing the U.S. national security state and Silicon Valley even closer together.

Max Jones
Jul 03, 2024

The WHO: Building a Permanent Pandemic Market

The WHO: Building a Permanent Pandemic Market

Facing a wave of patent cliffs, Big Pharma is betting on risky biotech. The WHO’s revised pandemic treaty, shaped by its private funders, would build a permanent market for this biotech despite its past regulatory challenges.

Max Jones
Your link has expired. Please request a new one.
Your link has expired. Please request a new one.
Your link has expired. Please request a new one.
Great! You've successfully signed up.
Great! You've successfully signed up.
Welcome back! You've successfully signed in.
Success! You now have access to additional content.